“…Thirteen studies in the pre-TBSRTC [13,14,15,16,17,18,19,20,21,22,23,24,25] and 8 studies in the post-TBSRTC [11,26,27,28,29,30,32,33] provided the specific histopathological diagnoses for their cases with malignant follow-up, and these are detailed in table 3. From this data, the rate of the follicular variant of papillary thyroid carcinoma (FV-PTC) as a fraction of all malignancy was equivalent, i.e.…”